Clinical trials recruiting for Liver Cirrhosis
19
Recruiting trials
13
US states with sites
11
Countries
11%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Phase 4 1Not applicable 16
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Encapsulated FMT | 1 |
| Foscenvivint | 1 |
| Injection of a gadolinium contrast agen | 1 |
| Non-selective beta-blockers | 1 |
| Radiotracer Injection | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Massachusetts | 2 |
| Minnesota | 2 |
| Texas | 2 |
| Illinois | 1 |
| Indiana | 1 |
| Michigan | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
Top cities
Dallas, Texas 2Minneapolis, Minnesota 2Ann Arbor, Michigan 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Charlestown, Massachusetts 1Chicago, Illinois 1Cleveland, Ohio 1Coon Rapids, Minnesota 1Detroit, Michigan 1
Self-screener
Recruiting trials
- A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
- A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
- Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
- Austrian PBC Registry
- Cirrhosis, Effects of TRAnsplantation and Diabetes
- Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Digital Early Warning System for Acute Lung Injury in Liver Surgery
- Early TIPS in Patients With Liver Cirrhosis and Ascites
- Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
- Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement
- Freiburg TIPS Registry
- National Liver Cancer Screening Trial
- Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss
- Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
- Relevance of Sarcopenia in Advanced Liver Disease
- The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
- VICIS - Vienna Cirrhosis Study
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Related conditions
Trials recruiting for Liver Cirrhosis often also study these conditions. Each links to its own recruiting-trial list.
Hypertension 1201Portal Hypertension 35Type 2 diabetes 891Non-Cirrhotic Portal Hypertension 4NASH 218Lung cancer 2180Hepatitis B 147Hepatic Encephalopathy 6Tuberculosis 14Sarcopenia 45
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Liver Cirrhosis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.